Pharmaceutical Linctus

Pharmaceutical Linctus Market Outlook

The global Pharmaceutical Linctus market is poised for significant growth, projected to reach approximately USD 1.5 billion by 2035, expanding at a CAGR of around 4.5% from 2025 to 2035. This growth can be attributed to increasing incidence rates of respiratory disorders, heightened consumer awareness regarding over-the-counter medications, and advancements in pharmaceutical formulations. The shift in consumer preferences toward effective cough and cold treatments, particularly during seasonal outbreaks, underscores the demand for pharmaceutical linctus products. Additionally, the rise of e-commerce platforms has facilitated easier access to these products, further driving market growth. Increased investment in research and development by pharmaceutical companies to innovate and improve formulation efficacy is expected to bolster market dynamics significantly.

Growth Factor of the Market

The Pharmaceutical Linctus market is primarily driven by the escalating prevalence of respiratory ailments such as bronchitis, asthma, and seasonal allergies, necessitating effective cough relief solutions. The rising awareness among consumers about the benefits and availability of herbal and natural ingredients in cough syrups has shifted preferences towards these products, potentially enhancing market growth. Furthermore, the growing aging population, which is more vulnerable to respiratory illnesses, contributes to the rising demand for effective linctus formulations. There’s also a notable increase in the health and wellness trend, where consumers are gravitating towards products that are perceived as safe and effective. Additionally, the expansion of distribution channels, especially through online pharmacies, is transforming the way consumers access pharmaceutical linctus, promoting market expansion.

Key Highlights of the Market

• Projected global market size of approximately USD 1.5 billion by 2035.
• Significant growth driven by increasing respiratory health concerns.
• A rising trend towards herbal and natural ingredient-based linctus products.
• Expansion in distribution channels, notably online platforms.
• Increased R&D investment in innovative formulation technologies.

By Product Type

Antitussive Linctus:

Antitussive linctus formulations are designed to suppress the cough reflex, providing relief to patients suffering from dry coughs. These products typically contain ingredients such as dextromethorphan or codeine, which are effective in reducing the frequency of coughing by acting on the cough center in the brain. The demand for antitussive linctus is growing due to increased awareness about respiratory issues and the need for effective symptomatic relief. Additionally, the availability of these products in both prescription and over-the-counter formats facilitates their accessibility, further boosting market growth.

Expectorant Linctus:

Expectorant linctus is formulated to promote the expulsion of mucus from the respiratory tract, making it particularly useful for patients dealing with productive coughs. Ingredients like guaifenesin are commonly included to thin mucus, enabling easier clearance from the airways. As respiratory infections and conditions like bronchitis and pneumonia become more prevalent, the demand for expectorant linctus is expected to rise. The growing trend towards multi-symptom relief products is also driving innovation in this segment, with manufacturers developing combinations that address both coughing and congestion.

Demulcent Linctus:

Demulcent linctus serves as a soothing agent for irritated throats, providing relief from soreness and discomfort. These formulations commonly contain ingredients such as honey or glycerin, which coat the throat and alleviate irritation. The increasing preference for natural and soothing remedies has contributed to the growth of this market segment. As consumers become more health-conscious, there is a significant shift towards products that provide a gentle approach to treating throat discomfort, making demulcent linctus an appealing option for many.

Mucolytic Linctus:

Mucolytic linctus formulations are designed to break down and thin mucus, facilitating easier breathing for patients with respiratory tract infections. These products are especially valuable for individuals suffering from chronic conditions such as COPD or cystic fibrosis. The growing awareness of chronic respiratory diseases and the need for efficient management options are propelling the demand for mucolytic linctus. Manufacturers are focusing on developing more effective and palatable formulations to cater to diverse patient preferences, which is further stimulating this segment of the market.

Bronchodilator Linctus:

Bronchodilator linctus is designed to relax and open the airways, making breathing easier for patients experiencing bronchospasm. This type of linctus often includes active ingredients that target bronchial muscles, providing symptomatic relief for individuals with asthma or chronic bronchitis. The increased incidence of asthma and other respiratory conditions is driving demand for bronchodilator linctus formulations. Furthermore, as awareness around the importance of managing these conditions grows, patients are increasingly seeking effective linctus solutions to enhance their quality of life.

By Application

Cough Suppressant:

Cough suppressants are a primary application for pharmaceutical linctus, providing immediate relief from persistent coughing. These products are vital during cold and flu season when symptoms can be particularly bothersome. The effectiveness of cough suppressants in improving patient comfort and sleep quality drives their popularity, resulting in a consistent demand. With a growing emphasis on symptom management, many consumers are opting for linctus formulations specifically designed to suppress coughs, ensuring they remain a significant segment within the market.

Chest Congestion Relief:

Linctus formulations aimed at relieving chest congestion are becoming increasingly popular as they address a common symptom associated with various respiratory conditions. These products work by thinning mucus and promoting its expulsion, thus alleviating the sensation of tightness in the chest. The rise of respiratory infections, particularly in the post-pandemic era, has heightened demand for congestion relief formulations, leading to innovations in product offerings. Manufacturers are also focusing on creating multi-symptom relief products that combine cough and congestion relief, enhancing their appeal to consumers.

Sore Throat Treatment:

Pharmaceutical linctus designed for sore throat relief provides soothing effects for individuals experiencing discomfort due to irritation or infection. These formulations often include demulcents or analgesics that help in alleviating pain and inflammation. The increased incidence of viral infections and seasonal illnesses is driving the demand for sore throat treatments. Consumers are looking for effective over-the-counter options that provide quick relief, making this application a critical component of the linctus market.

Respiratory Support:

Linctus formulations that focus on providing comprehensive respiratory support are gaining traction as they address multiple symptoms associated with respiratory conditions. These products often combine ingredients that soothe, suppress coughs, and relieve congestion, providing holistic care. The growing awareness of respiratory health and the need for effective management solutions are propelling this segment's growth. With an increasing number of patients seeking all-in-one products, respiratory support linctus is becoming an essential part of the therapeutic landscape.

Others:

This segment encompasses additional applications of pharmaceutical linctus that may include formulations specifically targeting other symptoms or conditions related to respiratory health. These may include products aimed at enhancing lung function or those designed for specific demographics, such as pediatric formulations. The versatility of pharmaceutical linctus allows for innovation in this area, catering to diverse patient needs and contributing to overall market growth. As research continues to highlight various aspects of respiratory health, additional applications are likely to emerge, fueling further market expansion.

By Distribution Channel

Online Pharmacies:

Online pharmacies have transformed the way consumers access pharmaceutical linctus products, offering convenience and a wide selection of options. The growth of e-commerce has seen an increase in the preference for purchasing medications online, especially following the COVID-19 pandemic, which emphasized the importance of contactless shopping. Online platforms often provide competitive pricing, detailed product information, and customer reviews that assist in informed purchasing decisions. The ease of access to products, combined with home delivery options, has significantly contributed to the growth of this distribution channel.

Retail Pharmacies:

Retail pharmacies remain a traditional and essential channel for the distribution of pharmaceutical linctus. These establishments provide immediate access to medications, allowing consumers to quickly obtain necessary products. The presence of trained pharmacists also adds a layer of credibility, as they can offer professional advice and recommendations regarding product selection. The combination of convenience and personal interaction ensures that retail pharmacies continue to play a vital role in the pharmaceutical linctus market, catering to patients' immediate needs effectively.

Hospital Pharmacies:

Hospital pharmacies are critical in providing pharmaceutical linctus to inpatients and outpatients requiring respiratory treatments. These pharmacies focus on delivering specialized care, including compounded formulations tailored to individual patient needs. The increasing focus on patient-centric care within healthcare institutions has led to greater investments in hospital pharmacy services, enhancing their role in the overall market. As hospitals aim to provide comprehensive respiratory care, the demand for pharmaceutical linctus within these settings is expected to grow.

Drug Stores:

Drug stores serve as a key distribution channel for pharmaceutical linctus, providing a comprehensive range of health products, including prescription and over-the-counter medications. Their accessibility and extensive product offerings make them a popular choice for consumers seeking cough and cold remedies. The convenience of drug stores, often located in high-traffic areas, allows for easy access to linctus products, catering to the immediate needs of consumers. As these establishments continue to expand their offerings and adapt to consumer preferences, they will remain an essential part of the linctus market.

Others:

This category encompasses alternative distribution channels such as specialty health stores, supermarkets, and convenience stores. While these outlets may not be the primary source for pharmaceutical linctus, they provide additional access points for consumers seeking cough and cold remedies. The diversification of distribution channels reflects changing consumer behaviors and preferences, ensuring that pharmaceutical linctus products are widely available in various retail environments. Continued efforts by manufacturers to partner with diverse retailers are likely to enhance market penetration and accessibility.

By Ingredient Type

Codeine-based:

Codeine-based linctus formulations are among the most effective options for providing cough relief, as codeine acts as a potent cough suppressant. These products are often prescribed for severe coughs associated with conditions like bronchitis and can be highly effective in managing symptoms. However, due to potential side effects and concerns regarding dependency, the use of codeine-based linctus is typically regulated, making them available only through prescriptions in many regions. The cautious yet necessary role of codeine in cough management ensures that this ingredient type remains a significant segment within the market.

Dextromethorphan-based:

Dextromethorphan is a widely recognized active ingredient in over-the-counter cough medicines, including pharmaceutical linctus. Its effectiveness in suppressing coughs without the addictive properties associated with codeine makes it a popular choice for consumers. Dextromethorphan-based linctus is commonly used for the management of dry coughs and is available in various formulations, appealing to a broad audience. The growing acceptance of dextromethorphan as a safe and effective cough suppressant is driving demand and solidifying its position as a key ingredient type within the market.

Guaifenesin-based:

Guaifenesin is a well-known expectorant used in linctus formulations aimed at relieving chest congestion. By thinning mucus, guaifenesin facilitates easier expulsion, making it ideal for patients with productive coughs. Its prevalence in both prescription and over-the-counter products highlights its importance within the linctus market. The increasing focus on combination therapies that address multiple symptoms simultaneously has led to a surge in the development of guaifenesin-based linctus products, enhancing patient experiences and improving treatment outcomes.

Honey-based:

Honey-based linctus formulations are gaining popularity due to their natural soothing properties and appeal to health-conscious consumers. Honey has long been recognized for its antimicrobial and anti-inflammatory effects, making it an ideal ingredient for soothing sore throats and coughs. The growing trend towards natural remedies and herbal solutions has fueled demand for honey-based products, particularly among consumers seeking alternatives to synthetic medications. This ingredient type reflects the increasing consumer preference for natural health solutions, positioning honey-based linctus as a key player in the market.

Herbal-based:

Herbal-based linctus products are becoming increasingly popular as consumers turn to natural ingredients for relief from respiratory symptoms. These formulations often incorporate a variety of herbs known for their therapeutic properties, such as thyme, marshmallow root, and licorice. The rising awareness of the potential benefits of herbal remedies, coupled with the growing skepticism towards synthetic chemicals, has significantly boosted the demand for herbal-based linctus. As manufacturers innovate and enhance these formulations, the herbal-based segment is expected to thrive, catering to a diverse range of consumer preferences.

By Region

The Pharmaceutical Linctus market exhibits varying dynamics across different regions, each influenced by local healthcare practices, consumer preferences, and regulatory environments. North America holds a significant share of the market, primarily driven by a high prevalence of respiratory ailments and a well-established healthcare infrastructure. The region is expected to witness a CAGR of 4.2% during the forecast period, as the demand for effective cough management solutions continues to rise. The presence of major pharmaceutical companies and a growing trend toward online purchasing further bolster the market in this region.

Europe also represents a substantial portion of the Pharmaceutical Linctus market, driven by an increasing awareness of respiratory health and the availability of a variety of cough syrups. The expansion of both retail and online pharmacies in countries like Germany, the UK, and France is expected to enhance accessibility to linctus products, further stimulating growth. The Asia Pacific region is anticipated to register the highest growth rate in the coming years, with a projected CAGR of 5.0%, attributed to rising healthcare spending, growing awareness of respiratory disorders, and an expanding middle-class population seeking effective cough relief solutions. Latin America and the Middle East & Africa are also experiencing gradual growth, driven by increasing demand for over-the-counter medications and improved healthcare access.

Opportunities

The Pharmaceutical Linctus market is poised for numerous growth opportunities, particularly through innovations in product development. The rising consumer preference for natural and herbal remedies presents a significant chance for manufacturers to expand their product lines. By focusing on developing novel formulations that combine efficacy with natural ingredients, companies can cater to the growing segment of health-conscious consumers. Furthermore, partnerships with health practitioners and pharmacies can enhance product visibility, encouraging more consumers to consider linctus as a viable treatment option. As research continues to shed light on the benefits of various herbal constituents, there’s potential for creating specialized products targeting specific respiratory conditions, which can contribute substantially to market growth.

Moreover, the increasing penetration of e-commerce in healthcare creates a unique opportunity for pharmaceutical linctus manufacturers to reach a broader audience. By investing in digital marketing and establishing a robust online presence, companies can tap into the growing trend of online shopping for healthcare products. The expansion of telemedicine and online consultations also provides an avenue for promoting linctus products directly to patients, enhancing accessibility and driving sales. Additionally, emerging markets in the Asia Pacific and Latin America regions present untapped opportunities due to their growing population and rising awareness of respiratory health. As healthcare systems in these regions continue to improve, the demand for pharmaceutical linctus is likely to rise, providing companies with a fertile ground for expansion.

Threats

The Pharmaceutical Linctus market faces several threats that could impact its growth trajectory. One of the primary concerns is the increasing competition from alternative therapies, including homeopathic and herbal treatments, which may appeal to consumers seeking natural remedies. The skepticism surrounding pharmaceutical products, especially those containing synthetic ingredients, can deter consumers from traditional linctus formulations. Additionally, regulatory challenges and the need for stringent compliance with safety standards may hinder market entry for new players, limiting innovation and product diversity. The potential for adverse effects or drug interactions associated with certain linctus ingredients also raises concerns among healthcare professionals and consumers alike, necessitating thorough education and transparency from manufacturers.

Another significant threat to the market is the rising cost of raw materials and manufacturing, which can lead to price increases for end consumers. This could potentially drive customers towards cheaper, unregulated alternatives that may not meet safety and efficacy standards. Furthermore, fluctuations in raw material availability due to environmental factors or geopolitical issues can disrupt supply chains, creating uncertainty in product availability. Staying ahead of these threats requires companies to adopt proactive strategies, including diversifying sourcing channels and investing in research to enhance the safety and effectiveness of their products.

Competitor Outlook

• GlaxoSmithKline plc
• Pfizer Inc.
• Johnson & Johnson
• Bristol-Myers Squibb Company
• Sanofi S.A.
• Novartis AG
• Merck & Co., Inc.
• Haleon plc
• Reckitt Benckiser Group plc
• AbbVie Inc.
• Procter & Gamble Co.
• Teva Pharmaceutical Industries Ltd.
• Amgen Inc.
• GSK Consumer Healthcare
• Sun Pharmaceutical Industries Ltd.

The competitive landscape of the Pharmaceutical Linctus market is characterized by the presence of both established pharmaceutical companies and emerging players. Major companies like GlaxoSmithKline, Pfizer, and Johnson & Johnson dominate the market with a broad portfolio of well-recognized linctus formulations. These companies leverage their extensive research and development capabilities to innovate and improve existing products, ensuring they meet consumer needs and regulatory requirements. Additionally, their strong distribution networks and marketing strategies allow them to maintain a robust market presence. Collaboration with healthcare providers and pharmacists is also a common strategy employed by these companies to enhance product visibility and consumer trust.

Emerging players are increasingly focusing on niche markets, particularly those catering to natural and herbal linctus formulations. Companies such as Haleon and Reckitt Benckiser are expanding their product lines to include herbal and demulcent options that appeal to health-conscious consumers. The trend towards personalization in healthcare is prompting these companies to explore unique formulations that target specific demographics, such as pediatric linctus or products formulated for the elderly. As the market evolves, competition is expected to intensify, with companies needing to adapt to changing consumer preferences and regulatory landscapes to remain successful.

Furthermore, strategic mergers and acquisitions are becoming common in the Pharmaceutical Linctus space, as companies seek to expand their market share and enhance their product offerings. For instance, collaborations between pharmaceutical giants and herbal supplement manufacturers can lead to the development of innovative products that combine the benefits of both pharmaceutical and natural ingredients. This trend not only fosters growth but also ensures that companies can cater to a broader audience. As the market continues to mature, maintaining a competitive edge will require ongoing investment in research, robust marketing strategies, and a commitment to consumer safety and satisfaction.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Amgen Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Haleon plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 AbbVie Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Novartis AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Pfizer Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Sanofi S.A.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Johnson & Johnson
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Merck & Co., Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 GlaxoSmithKline plc
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Procter & Gamble Co.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 GSK Consumer Healthcare
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Reckitt Benckiser Group plc
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Bristol-Myers Squibb Company
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Sun Pharmaceutical Industries Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Teva Pharmaceutical Industries Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Pharmaceutical Linctus Market, By Application
    • 6.1.1 Cough Suppressant
    • 6.1.2 Chest Congestion Relief
    • 6.1.3 Sore Throat Treatment
    • 6.1.4 Respiratory Support
    • 6.1.5 Others
  • 6.2 Pharmaceutical Linctus Market, By Product Type
    • 6.2.1 Antitussive Linctus
    • 6.2.2 Expectorant Linctus
    • 6.2.3 Demulcent Linctus
    • 6.2.4 Mucolytic Linctus
    • 6.2.5 Bronchodilator Linctus
  • 6.3 Pharmaceutical Linctus Market, By Ingredient Type
    • 6.3.1 Codeine-based
    • 6.3.2 Dextromethorphan-based
    • 6.3.3 Guaifenesin-based
    • 6.3.4 Honey-based
    • 6.3.5 Herbal-based
  • 6.4 Pharmaceutical Linctus Market, By Distribution Channel
    • 6.4.1 Online Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Hospital Pharmacies
    • 6.4.4 Drug Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Pharmaceutical Linctus Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Pharmaceutical Linctus market is categorized based on

By Product Type

• Antitussive Linctus
• Expectorant Linctus
• Demulcent Linctus
• Mucolytic Linctus
• Bronchodilator Linctus

By Application

• Cough Suppressant
• Chest Congestion Relief
• Sore Throat Treatment
• Respiratory Support
• Others

By Distribution Channel

• Online Pharmacies
• Retail Pharmacies
• Hospital Pharmacies
• Drug Stores
• Others

By Ingredient Type

• Codeine-based
• Dextromethorphan-based
• Guaifenesin-based
• Honey-based
• Herbal-based

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• GlaxoSmithKline plc
• Pfizer Inc.
• Johnson & Johnson
• Bristol-Myers Squibb Company
• Sanofi S.A.
• Novartis AG
• Merck & Co., Inc.
• Haleon plc
• Reckitt Benckiser Group plc
• AbbVie Inc.
• Procter & Gamble Co.
• Teva Pharmaceutical Industries Ltd.
• Amgen Inc.
• GSK Consumer Healthcare
• Sun Pharmaceutical Industries Ltd.